Article metrics

Download PDFPDF
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

 

Online download statistics by month:

Online download statistics by month: April 2018 to December 2021

AbstractFullPdf
Apr 20181435201138
May 20182499411325
Jun 20181019166118
Jul 20182240362256
Aug 20181422299221
Sep 20181005226187
Oct 2018993191136
Nov 2018642127105
Dec 20184559370
Jan 2019674158132
Feb 2019639111115
Mar 20195277576
Apr 20193759688
May 20194067455
Jun 20195448496
Jul 20194479088
Aug 20195549596
Sep 20196419188
Oct 20196779783
Nov 20196018277
Dec 20195347055
Jan 20205268496
Feb 20205425972
Mar 20204756661
Apr 20204245166
May 20204696472
Jun 20206508682
Jul 20205356668
Aug 20204746352
Sep 20205848977
Oct 20204735958
Nov 20205256566
Dec 20205846458
Jan 20219286956
Feb 20217277585
Mar 20217346570
Apr 20215646350
May 20213376573
Jun 2021856549
Jul 2021614742
Aug 2021896051
Sep 2021857268
Oct 20214617673
Nov 202173213772
Dec 20215647763
Total2995748864185